Nantahala Capital Management, LLC / AURA
Nantahala Capital Management, LLC’s Aura Biosciences Inc Position
Does Nantahala Capital Management, LLC own Aura Biosciences Inc (AURA)? Yes — 2.12M shares worth $14M (+0.52% of its 13F portfolio) as of Q1 2026.
Position Value
$14M
Q1 2026
Shares
2.12M
% of Portfolio
+0.52%
Quarters Held
18
currently held
Position History AURA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.12M | $14M | +0.52% |
| Q4 2025 | 2.12M | $12M | +0.38% |
| Q3 2025 | 2.12M | $13M | +0.45% |
| Q2 2025 | 2.12M | $13M | +0.52% |
| Q1 2025 | 1.27M | $7M | +0.30% |
| Q4 2024 | 1.27M | $10M | +0.45% |
| Q3 2024 | 1.27M | $11M | +0.57% |
| Q2 2024 | 2.54M | $19M | +0.56% |
| Q1 2024 | 1.32M | $10M | +0.59% |
| Q4 2023 | 2.64M | $23M | +0.70% |
| Q3 2023 | 743.9K | $7M | +0.57% |
| Q2 2023 | 803.3K | $10M | +0.96% |
| Q1 2023 | 843.4K | $8M | +0.60% |
| Q4 2022 | 798.8K | $8M | +0.54% |
| Q3 2022 | 383.8K | $7M | +0.45% |
| Q2 2022 | 343.2K | $5M | +0.24% |
| Q1 2022 | 302.0K | $7M | +0.29% |
| Q4 2021 | 99.1K | $2M | +0.06% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nantahala Capital Management, LLC’s full portfolio or all institutional holders of AURA.